{
    "hands_on_practices": [
        {
            "introduction": "A cornerstone of dermatologic assessment is quantifying the extent of a skin condition, which directly influences treatment decisions. A simple yet powerful tool for this is estimating the involved Body Surface Area ($BSA$). This exercise provides hands-on practice with the \"palm method,\" a widely used clinical heuristic to translate the physical extent of a rash into a standardized severity score, a critical step in clinical decision-making .",
            "id": "4953272",
            "problem": "In introductory clinical dermatology, the extent of a cutaneous eruption is frequently estimated by relating the involved skin area to the patient's total body surface area (BSA). A well-tested clinical rule of thumb is that the patient's palm excluding fingers approximates $1\\%$ of total body surface area. Extent categories are often operationalized for decision-making in common disorders such as psoriasis and atopic dermatitis by using BSA thresholds. Consider a patient with a generalized maculopapular rash covering $18$ of the patient's palms (excluding fingers).\n\nStarting from the following foundational facts:\n- The palm method: one patient palm excluding fingers approximates $1\\%$ of total body surface area.\n- The BSA involved is computed by summing the number of involved palms and converting the percentage into a decimal fraction of the total body surface area.\n- Extent categories by BSA (expressed as decimal fractions) for clinical decision-making: mild if $0<\\text{BSA}<0.03$, moderate if $0.03\\le \\text{BSA}\\le 0.10$, severe if $\\text{BSA}>0.10$.\n\nUsing these bases, determine the decimal fraction of BSA involved by the rash, and then assign the extent category using the following numeric codes: mild $\\to 1$, moderate $\\to 2$, severe $\\to 3$. Express the BSA as a decimal fraction (do not use a percentage sign) and round the BSA value to $3$ significant figures. Provide your final answer as a row matrix $\\begin{pmatrix}\\text{BSA fraction} & \\text{category code}\\end{pmatrix}$ with no units.",
            "solution": "The problem is first assessed for validity.\n\n### Step 1: Extract Givens\n- A patient's palm excluding fingers approximates $1\\%$ of total body surface area (BSA). This is termed the \"palm method\".\n- A patient has a rash covering an area equivalent to $18$ of the patient's palms.\n- The BSA involved is computed by summing the number of involved palms and converting the percentage into a decimal fraction.\n- Extent categories by BSA (as a decimal fraction):\n    - mild: $0 < \\text{BSA} < 0.03$\n    - moderate: $0.03 \\le \\text{BSA} \\le 0.10$\n    - severe: $\\text{BSA} > 0.10$\n- Numeric codes for extent categories:\n    - mild $\\to 1$\n    - moderate $\\to 2$\n    - severe $\\to 3$\n- The BSA must be expressed as a decimal fraction, rounded to $3$ significant figures.\n- The final answer is to be a row matrix: $\\begin{pmatrix}\\text{BSA fraction} & \\text{category code}\\end{pmatrix}$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded in the context of clinical dermatology, as the \"rule of palm\" is a standard heuristic used for estimating body surface area involvement. The BSA thresholds provided for categorizing disease severity are also consistent with clinical practice for common inflammatory skin diseases. The problem is well-posed, providing all necessary data and explicit, non-contradictory rules for calculation and classification. The language is objective and precise. The problem does not violate any criteria for validity.\n\n### Step 3: Verdict and Action\nThe problem is deemed valid. A solution will be provided.\n\n### Solution\nLet $N_p$ be the number of palm areas covered by the rash. According to the problem statement, $N_p = 18$.\nLet $A_{palm\\%}$ be the percentage of total body surface area (BSA) approximated by one palm area. The problem states that $A_{palm\\%} = 1\\%$.\n\nThe total percentage of BSA involved, denoted as $BSA_{\\%}$, is the product of the number of palm areas and the percentage per palm.\n$$BSA_{\\%} = N_p \\times A_{palm\\%}$$\nSubstituting the given values:\n$$BSA_{\\%} = 18 \\times 1\\% = 18\\%$$\nThe problem requires the BSA to be expressed as a decimal fraction, which we denote as $BSA_{frac}$. To convert a percentage to a decimal fraction, we divide by $100$.\n$$BSA_{frac} = \\frac{BSA_{\\%}}{100}$$\n$$BSA_{frac} = \\frac{18}{100} = 0.18$$\nThe problem specifies that this value must be rounded to $3$ significant figures. The number $0.18$ has two significant figures (the leading zero is not significant). To express this with three significant figures, we must add a trailing zero, which is significant.\n$$BSA_{frac, rounded} = 0.180$$\nNext, we must assign an extent category based on the value of $BSA_{frac, rounded}$. The given categories are:\n- mild if $0 < BSA_{frac} < 0.03$\n- moderate if $0.03 \\le BSA_{frac} \\le 0.10$\n- severe if $BSA_{frac} > 0.10$\n\nWe compare our calculated value, $BSA_{frac, rounded} = 0.180$, to these thresholds.\nSince $0.180 > 0.10$, the condition for the \"severe\" category is met.\n\nThe problem requires a numeric code for the category, with the following mapping:\n- mild $\\to 1$\n- moderate $\\to 2$\n- severe $\\to 3$\nAs the category is severe, the corresponding numeric code is $3$.\n\nFinally, the answer must be presented as a row matrix $\\begin{pmatrix}\\text{BSA fraction} & \\text{category code}\\end{pmatrix}$.\nSubstituting our results, the matrix is $\\begin{pmatrix} 0.180 & 3 \\end{pmatrix}$.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.180 & 3 \\end{pmatrix}}$$"
        },
        {
            "introduction": "Effective diagnosis often goes beyond memorizing symptoms to understanding how underlying disease processes create specific clinical signs. This practice focuses on the crucial skill of differential diagnosis by challenging you to deduce the classic features of scalp psoriasis and seborrheic dermatitis from their fundamental pathophysiology. By reasoning from first principles, you will learn to distinguish these common conditions and determine the appropriate use of diagnostic tools like a biopsy .",
            "id": "4953256",
            "problem": "A clinician is presented with a patient who has chronic scalp scaling and erythema. The goal is to distinguish between scalp psoriasis and seborrheic dermatitis using first principles of dermatologic pathophysiology and morphology, rather than relying on memorized lists. Begin from the following foundational base:\n\n- Psoriasis is a chronic immune-mediated inflammatory disease characterized by accelerated keratinocyte turnover, parakeratosis, and a robust interface between involved and uninvolved skin. These processes determine the properties of the stratum corneum and the sharpness of lesion borders.\n- Seborrheic dermatitis is an inflammatory condition of sebaceous-rich skin driven by host response to commensal yeasts, altered barrier function, and sebum-associated changes in the stratum corneum. These processes determine the quality of scale and the diffuseness of involvement.\n- In clinical dermatology, the principle of minimally invasive diagnosis prioritizes a clinical pattern-recognition approach when characteristic features are present, reserving invasive tests for cases in which a change in management depends on excluding serious or alternative diagnoses.\n\nUsing these bases, infer how the underlying processes yield differences in the quality of scale, the definition of lesion margins, and the propensity of lesions to extend beyond the hairline as a sharply bordered band on adjacent facial skin. Then, apply the diagnostic minimalism principle to determine when a scalp biopsy is warranted in this differential.\n\nWhich option best integrates these distinctions and the indication for biopsy?\n\nA. Compared to seborrheic dermatitis, scalp psoriasis typically shows thick, dry, micaceous scale over well-demarcated erythematous plaques and commonly forms a sharply bordered band that crosses onto the forehead or postauricular skin, whereas seborrheic dermatitis shows greasy, yellowish scale with ill-defined margins and is less likely to produce a sharply demarcated band beyond the hairline; biopsy is reserved for atypical or overlapping presentations, suspicion of scarring alopecia or fungal infection, or failure of appropriate therapy, not for routine confirmation in classic cases.\n\nB. Psoriasis usually presents with greasy scale and ill-defined patches on the scalp, while seborrheic dermatitis shows silvery micaceous scale with sharp borders; a sharply defined band crossing the hairline is more characteristic of seborrheic dermatitis than psoriasis; biopsy should routinely be performed to confirm the diagnosis before treatment.\n\nC. Scale quality and margin definition are unreliable for distinguishing scalp psoriasis from seborrheic dermatitis; the only practical discriminator is nail pitting, and hairline extension is not useful; biopsy should always be avoided because it does not change management.\n\nD. Seborrheic dermatitis typically produces thin, dry scale with sharply demarcated plaques that often extend beyond the hairline in a band, while psoriasis is confined within the hairline; biopsy is indicated whenever pruritus is severe, regardless of clinical morphology.",
            "solution": "### Step 1: Extract Givens\nThe foundational statements provided in the problem are:\n- **Psoriasis**: A chronic immune-mediated inflammatory disease characterized by accelerated keratinocyte turnover, parakeratosis, and a robust interface between involved and uninvolved skin. These processes are stated to determine the properties of the stratum corneum and the sharpness of lesion borders.\n- **Seborrheic dermatitis**: An inflammatory condition of sebaceous-rich skin driven by host response to commensal yeasts, altered barrier function, and sebum-associated changes in the stratum corneum. These processes are stated to determine the quality of scale and the diffuseness of involvement.\n- **Principle of minimally invasive diagnosis**: This principle prioritizes a clinical pattern-recognition approach for characteristic presentations and reserves invasive tests, such as biopsy, for cases where a change in management is contingent on excluding serious or alternative diagnoses.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement provides a set of pathophysiological principles for two common dermatologic diseases and a guiding principle for clinical diagnosis, then asks the user to infer the resulting clinical morphologies and the appropriate use of a diagnostic procedure.\n\n- **Scientifically Grounded**: The descriptions of psoriasis and seborrheic dermatitis are accurate and consistent with modern dermatological science. The link between accelerated keratinocyte turnover and parakeratosis in psoriasis is a fundamental concept in its pathophysiology, leading to the characteristic thick, adherent scale. The concept of a sharp inflammatory interface histologically corresponds to well-demarcated clinical plaques. Similarly, the description of seborrheic dermatitis involving *Malassezia* yeasts, sebum, and a resulting inflammatory response is the accepted etiological model, which explains its predilection for sebaceous areas and the typical greasy quality of the scale. The principle of minimally invasive diagnosis is a cornerstone of responsible and efficient medical practice. The problem is scientifically sound.\n- **Well-Posed**: The problem is well-posed. It requires a logical deduction from provided axioms (the pathophysiological statements) to a set of clinical conclusions. There is a clear question to be answered, and the provided information is sufficient to derive a logical answer.\n- **Objective**: The language is clinical, precise, and devoid of subjective or biased assertions.\n\nThe problem statement is valid. It presents a standard exercise in clinical reasoning, requiring the integration of foundational science with clinical morphology and diagnostic strategy.\n\n### Step 3: Derivation of Clinical Features and Biopsy Indications\n\n**Analysis from First Principles:**\n\n1.  **Psoriasis Morphology**:\n    - The \"accelerated keratinocyte turnover\" and \"parakeratosis\" mean that epidermal cells (keratinocytes) proliferate too quickly and reach the surface (stratum corneum) before they can fully mature and lose their nuclei. This dysfunctional maturation process results in a thickened, abnormal stratum corneum that is poorly adherent to itself and accumulates. Clinically, this manifests as **thick, dense scale**. The scale is typically dry and often described as silvery or **micaceous** (like flakes of mica).\n    - The \"robust interface between involved and uninvolved skin\" describes a sharp inflammatory demarcation at the microscopic level. This translates directly into a macroscopic clinical finding: the erythematous (red) plaques of psoriasis have **well-demarcated** or **sharply defined** borders.\n    - If such a process extends from the scalp onto adjacent non-hair-bearing skin (e.g., the forehead, neck, or postauricular skin), it will retain its fundamental characteristics. Therefore, it would form a **sharply bordered band** of erythema and scale.\n\n2.  **Seborrheic Dermatitis Morphology**:\n    - This condition is rooted in \"sebaceous-rich skin\" and involves \"sebum-associated changes\". The inflammatory response and abnormal keratinization occur in an environment rich in sebum (skin oil). When the excess stratum corneum flakes off, it is mixed with this sebum, resulting in a scale that is characteristically **greasy** or waxy in texture and often **yellowish** in color, rather than silvery-white.\n    - The pathophysiology is described as determining \"the diffuseness of involvement\". This implies a less intense and less organized inflammatory infiltrate at the margins compared to psoriasis. The clinical correlate is erythema with **ill-defined** or poorly demarcated borders. The affected areas tend to blend more gradually into the surrounding normal skin.\n    - Consequently, if seborrheic dermatitis extends beyond the hairline, it would likely do so in a diffuse manner, consistent with its underlying nature, and would be less likely to form a distinct, sharply bordered band.\n\n3.  **Indication for Scalp Biopsy**:\n    - The \"principle of minimally invasive diagnosis\" dictates that a clinical diagnosis is sufficient when the presentation is characteristic. Classic scalp psoriasis (thick, silvery scale on a well-demarcated plaque) and classic seborrheic dermatitis (greasy, yellow scale on an ill-defined patch) can usually be distinguished by clinical examination alone.\n    - An invasive test like a biopsy is reserved for situations where the diagnosis is ambiguous and the management would significantly change based on the result. Such situations include:\n        - **Atypical or overlapping presentations**: When features of both conditions are present (sometimes termed \"sebopsoriasis\"), a biopsy might be needed to identify the predominant pathology.\n        - **Suspicion of a more serious alternative diagnosis**: This includes scarring alopecias (e.g., lichen planopilaris), which can mimic inflammatory scalp conditions but lead to permanent hair loss and require aggressive treatment, or cutaneous lupus.\n        - **Suspicion of a different treatable condition**: For instance, a recalcitrant scalp eruption might be a tinea capitis (fungal infection) that requires systemic antifungal therapy rather than topical steroids or anti-inflammatory agents.\n        - **Failure of appropriate therapy**: If a patient with a presumed diagnosis of psoriasis or seborrheic dermatitis does not respond to standard, potent therapies, the diagnosis should be reconsidered, and a biopsy is warranted to confirm or refute the initial assessment.\n    - Therefore, a biopsy is **not** a routine procedure for every case of scalp scaling but a tool for specific, complex, or unresponsive cases.\n\n### Option-by-Option Analysis\n\n**A. Compared to seborrheic dermatitis, scalp psoriasis typically shows thick, dry, micaceous scale over well-demarcated erythematous plaques and commonly forms a sharply bordered band that crosses onto the forehead or postauricular skin, whereas seborrheic dermatitis shows greasy, yellowish scale with ill-defined margins and is less likely to produce a sharply demarcated band beyond the hairline; biopsy is reserved for atypical or overlapping presentations, suspicion of scarring alopecia or fungal infection, or failure of appropriate therapy, not for routine confirmation in classic cases.**\n- This option accurately describes the clinical features of both conditions as derived from the foundational principles. It correctly links psoriasis with thick, micaceous scale and sharp demarcation, and seborrheic dermatitis with greasy, yellowish scale and ill-defined margins. It correctly infers the nature of hairline extension for both. It then perfectly applies the principle of minimally invasive diagnosis, listing the correct and specific indications for a biopsy while stating it is not routine.\n- **Verdict: Correct.**\n\n**B. Psoriasis usually presents with greasy scale and ill-defined patches on the scalp, while seborrheic dermatitis shows silvery micaceous scale with sharp borders; a sharply defined band crossing the hairline is more characteristic of seborrheic dermatitis than psoriasis; biopsy should routinely be performed to confirm the diagnosis before treatment.**\n- This option reverses the classic descriptions of the two conditions. Psoriasis does not have greasy scale and ill-defined patches; seborrheic dermatitis does. Seborrheic dermatitis does not have silvery, micaceous scale and sharp borders; psoriasis does. The sharply defined band is characteristic of psoriasis, not seborrheic dermatitis. The statement that biopsy should be routine directly contradicts the provided principle of diagnostic minimalism.\n- **Verdict: Incorrect.**\n\n**C. Scale quality and margin definition are unreliable for distinguishing scalp psoriasis from seborrheic dermatitis; the only practical discriminator is nail pitting, and hairline extension is not useful; biopsy should always be avoided because it does not change management.**\n- This option claims that the very features derived from the provided principles (\"Scale quality and margin definition\") are unreliable, which contradicts the premise of the question. While nail pitting is a useful clue for psoriasis, it is not the \"only\" discriminator, and its absence does not rule out the diagnosis. The statement that biopsy should \"always be avoided\" is an incorrect absolute; as derived, there are specific, crucial indications for biopsy where it absolutely does change management.\n- **Verdict: Incorrect.**\n\n**D. Seborrheic dermatitis typically produces thin, dry scale with sharply demarcated plaques that often extend beyond the hairline in a band, while psoriasis is confined within the hairline; biopsy is indicated whenever pruritus is severe, regardless of clinical morphology.**\n- This option mischaracterizes seborrheic dermatitis as having dry scale and sharp plaques, which is the opposite of its typical presentation. It incorrectly states that psoriasis is confined within the hairline; it frequently extends beyond it. The indication for biopsy is also incorrect. Pruritus (itching) is a symptom, not a diagnostic sign, and its severity is not a primary trigger for biopsy, especially when the clinical morphology is clear. The key trigger is diagnostic uncertainty that impacts management.\n- **Verdict: Incorrect.**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Managing cutaneous melanoma requires a systematic approach that translates pathology findings into a precise stage and a concrete therapeutic plan. This exercise simulates this vital clinical task, asking you to apply established guidelines to a real-world scenario. You will use a biopsy report's key data points to determine the correct tumor stage, recommend surgical margins, and decide on the need for further staging with a sentinel lymph node biopsy .",
            "id": "4953275",
            "problem": "A $45$-year-old man presents with a newly noticed pigmented lesion on his upper back. An excisional biopsy shows invasive cutaneous melanoma with Breslow thickness $1.2\\ \\mathrm{mm}$. The pathology report notes no ulceration, a dermal mitotic rate of $2/\\mathrm{mm}^2$, and clear biopsy margins. There is no clinical lymphadenopathy on examination. Using core definitions and well-tested clinical frameworks for melanoma, determine the most accurate combination of primary tumor T category, recommended wide local excision margin, and whether sentinel lymph node biopsy (SLNB) should be offered.\n\nWhich option is most appropriate?\n\nA. $T2a$; wide local excision margin $1$ to $2\\ \\mathrm{cm}$; SLNB recommended\n\nB. $T2a$; wide local excision margin $0.5\\ \\mathrm{cm}$; SLNB not recommended\n\nC. $T2b$; wide local excision margin $2\\ \\mathrm{cm}$; SLNB recommended\n\nD. $T1b$; wide local excision margin $1\\ \\mathrm{cm}$; SLNB recommended only if mitotic rate $\\ge 1/\\mathrm{mm}^2$\n\nE. $T1a$; wide local excision margin $1\\ \\mathrm{cm}$; SLNB not recommended",
            "solution": "To derive the correct answer, start from foundational definitions and established, well-tested clinical frameworks.\n\n1. Primary tumor (T) category derivation from Breslow thickness and ulceration:\n- Breslow thickness is defined as the measured depth from the top of the epidermal granular layer (or base of an ulcer, if present) to the deepest malignant melanocyte, in $\\mathrm{mm}$.\n- The American Joint Committee on Cancer (AJCC) staging system (AJCC, $8$th edition) defines T categories primarily by Breslow thickness and ulceration status. The relevant cutpoints:\n  - $T1$: thickness $\\le 1.0\\ \\mathrm{mm}$,\n  - $T2$: thickness $1.01$ to $2.0\\ \\mathrm{mm}$,\n  - Suffix $a$ denotes non-ulcerated; suffix $b$ denotes ulcerated.\n- Mitotic rate is prognostic but is not used to define T subcategories in the AJCC $8$th edition.\n- The patientâ€™s melanoma has thickness $1.2\\ \\mathrm{mm}$ (which lies between $1.01$ and $2.0\\ \\mathrm{mm}$) and is non-ulcerated. Therefore, the primary tumor category is $T2a$.\n\n2. Wide local excision margin derivation from evidence-based surgical oncology recommendations:\n- Wide local excision margin recommendations are derived from randomized trials and consensus guidelines (for example, National Comprehensive Cancer Network (NCCN) and European Society for Medical Oncology) correlating margin width with local control and morbidity.\n- For invasive melanoma with thickness $1.01$ to $2.0\\ \\mathrm{mm}$, recommended margins are $1$ to $2\\ \\mathrm{cm}$ of normal skin around the scar, tailored by anatomic site and functional considerations. Margins narrower than $1\\ \\mathrm{cm}$ for lesions $>1\\,\\mathrm{mm}$ increase the risk of local recurrence; margins wider than $2\\ \\mathrm{cm}$ do not show additional benefit and may increase morbidity.\n- Thus, for $1.2\\ \\mathrm{mm}$ thickness, a margin of $1$ to $2\\ \\mathrm{cm}$ is appropriate.\n\n3. Sentinel lymph node biopsy (SLNB) indication reasoning from the biology of lymphatic spread and guideline thresholds:\n- SLNB identifies occult regional nodal metastasis by mapping the first draining lymph node(s) from the primary site.\n- The probability of sentinel node positivity rises with thickness and ulceration. Guidelines recommend SLNB for melanomas with thickness $\\ge 1.0\\ \\mathrm{mm}$, and consider SLNB for thickness $0.8$ to $1.0\\ \\mathrm{mm}$ if ulcerated or if other high-risk features are present.\n- Given thickness $1.2\\ \\mathrm{mm}$ and no ulceration, SLNB is recommended based on thickness alone.\n\nWith these derivations, the correct combination is $T2a$; wide local excision margin $1$ to $2\\ \\mathrm{cm}$; SLNB recommended.\n\nOption-by-option analysis:\n- A. $T2a$; wide local excision margin $1$ to $2\\ \\mathrm{cm}$; SLNB recommended.\n  - T category: Correct as derived above ($1.2\\ \\mathrm{mm}$, non-ulcerated $\\Rightarrow T2a$).\n  - Margin: Correct ($1$ to $2\\ \\mathrm{cm}$ for thickness $1.01$ to $2.0\\ \\mathrm{mm}$).\n  - SLNB: Correct (recommended for thickness $\\ge 1.0\\ \\mathrm{mm}$).\n  - Verdict: Correct.\n\n- B. $T2a$; wide local excision margin $0.5\\ \\mathrm{cm}$; SLNB not recommended.\n  - T category: Correct.\n  - Margin: Incorrect; $0.5\\ \\mathrm{cm}$ is insufficient for $>1.0\\,\\mathrm{mm}$ thickness and is reserved for melanoma in situ.\n  - SLNB: Incorrect; should be recommended at $1.2\\ \\mathrm{mm}$.\n  - Verdict: Incorrect.\n\n- C. $T2b$; wide local excision margin $2\\ \\mathrm{cm}$; SLNB recommended.\n  - T category: Incorrect; $T2b$ requires ulceration, which is absent. The correct is $T2a$.\n  - Margin: $2\\ \\mathrm{cm}$ is within the recommended range for $1.01$ to $2.0\\ \\mathrm{mm}$, but the incorrect T category invalidates the option.\n  - SLNB: Correct, but overall option remains incorrect due to misclassification of T.\n  - Verdict: Incorrect.\n\n- D. $T1b$; wide local excision margin $1\\ \\mathrm{cm}$; SLNB recommended only if mitotic rate $\\ge 1/\\mathrm{mm}^2$.\n  - T category: Incorrect; thickness $1.2\\ \\mathrm{mm}$ exceeds $1.0\\ \\mathrm{mm}$, so $T1$ categories do not apply. Additionally, AJCC $8$th edition does not use mitotic rate to assign $a/b$ subcategories.\n  - Margin: Although $1\\ \\mathrm{cm}$ can be acceptable within the $1$ to $2\\ \\mathrm{cm}$ range for $1.2\\ \\mathrm{mm}$ lesions in some contexts, the mis-staged T category and the conditional SLNB tied to mitotic rate are not aligned with current indications.\n  - SLNB: Incorrect rationale; indication at $1.2\\ \\mathrm{mm}$ is based on thickness, not a mitotic rate threshold.\n  - Verdict: Incorrect.\n\n- E. $T1a$; wide local excision margin $1\\ \\mathrm{cm}$; SLNB not recommended.\n  - T category: Incorrect; $1.2\\ \\mathrm{mm}$ is not within $T1$ ($\\le 1.0\\ \\mathrm{mm}$).\n  - Margin: $1\\ \\mathrm{cm}$ can be appropriate for $1.01$ to $2.0\\ \\mathrm{mm}$ thickness, but the T misclassification and SLNB omission make the option incorrect.\n  - SLNB: Incorrect; should be recommended at $1.2\\ \\mathrm{mm}$.\n  - Verdict: Incorrect.\n\nTherefore, the correct choice is option A.",
            "answer": "$$\\boxed{A}$$"
        }
    ]
}